Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 226 AL 240

Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non-pharmacological strategies

Martínez-Orozco H, Andrade-Guerrero J, Pastén-Castrejón NJ, Rodríguez-Tanty C, Diaz-Miranda SY.

Alzheimers Dement. 2026 Jun;22(6):e71589. doi: 10.1002/alz.71589.

Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer's disease: The paving dawn for future therapy

Al-Kuraishy HM, Fahad EH, Jabir MS, Rafeeq MF, Sulaiman GM, Amara IB, Albuhadily AK, Al-Gareeb AI.

Neuroscience. 2026 Sep 11;611:10-18. doi: 10.1016/j.neuroscience.2026.06.032. Epub 2026 Jun 24.

Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: A systematic review and network meta-analysis of phase III trials

Wu Y, Di Y, Wang H, Wang L, Zhang J, Zhang Y, Lyu D.

Ageing Res Rev. 2026 Aug;120:103216. doi: 10.1016/j.arr.2026.103216. Epub 2026 Jun 24.

Marine Lipids and Alzheimer's Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects

Gomes-Bispo A, Cardoso C, Afonso C, Lourenço HM, Pedro S, Moniz P, Bandarra NM.

Mar Drugs. 2026 Jun 3;24(6):197. doi: 10.3390/md24060197.

Age-dependent diagnostic and correlational architecture of multiplex plasma biomarkers in Alzheimer's disease: a cross-ethnic, cross-platform validation study

Jin B, Li A, Xu F, Chen C, Dong J, Wang J, Tang D, Gu Y, Liu H.

Alzheimers Res Ther. 2026 Jun 25;18(1):169. doi: 10.1186/s13195-026-02119-z.

From Tradition to Translation: A Critical Appraisal of Bacopa monnieri for Neuroprotection from Preclinical and Clinical Perspectives and Challenges in Utilization

Olajide AT, Aunsorn S, Kehinde SA, Kaewmanee T, Chusri S.

Int J Mol Sci. 2026 Jun 17;27(12):5488. doi: 10.3390/ijms27125488.

Multitarget Actions of Pentacyclic Triterpenic Acids in Alzheimer's Disease: Mechanistic Insights

Sharma N, An SSA.

Molecules. 2026 Jun 9;31(12):2018. doi: 10.3390/molecules31122018.

Dual-target inhibitors based on BuChE: A review from medicinal chemistry perspective

Ren C, Wang X, Yao Y, Liang S, Liao W, Yao Z.

Eur J Med Chem. 2026 Nov 5;317:119081. doi: 10.1016/j.ejmech.2026.119081. Epub 2026 Jun 23.

Network meta-analysis of different traditional Chinese medicine therapies as adjuvant treatments for Alzheimer's disease

Li Z, Bai X, Li J, Geng W, Xing X, Liang J, Li J, Li J.

Complement Ther Clin Pract. 2026 Aug;64:102075. doi: 10.1016/j.ctcp.2026.102075. Epub 2026 Jun 25.

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents

Lin Z, Hu L, Liu Y, Ning W, Wang S, Fu ZY, Guan L.

Bioorg Med Chem Lett. 2026 Nov;140:130716. doi: 10.1016/j.bmcl.2026.130716. Epub 2026 Jun 29.

Long-term effects of multisession gamma transcranial alternating current stimulation in Alzheimer's disease

Cantoni V, Grassi M, Premi E, Cupidi C, Zummo E, Cotelli MS, Benussi A, Borroni B.

J Alzheimers Dis. 2026 Aug;112(4):1759-1763. doi: 10.1177/13872877261461248. Epub 2026 Jun 30.

Therapeutic plasma exchange in Alzheimer's disease: From clinical trial to real-world evidence

Khatri BO.

Transfus Apher Sci. 2026 Aug;65(4):104481. doi: 10.1016/j.transci.2026.104481. Epub 2026 Jun 28.

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Hazan J, Liu KY, Howard R.

Alzheimers Dement. 2026 Jul;22(7):e71643. doi: 10.1002/alz.71643.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias